EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sustained Release of αO-Conotoxin GeXIVA[1,2] via Hydrogel Microneedle Patch for Chronic Neuropathic Pain Management

Rongyan He, Mingjuan Li, Weitao Li, Wenqi Li, Shuting Xiao, Qiuyu Cao, Huanbai Wang, Dongting Zhangsun, Sulan Luo iD

Marine Drugs · 2025

DOI: 10.3390/md23040161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Rongyan He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China. Hauptthemen laut MEDLINE: Neuralgia, Conotoxins, Analgesics, Chronic Pain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Intergovernmental Joint Research Project of National Key R & D Program of China, Guangxi Natural Science Foundation, Major International Joint Research Project of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic neuropathic pain severely impairs quality of life, with current therapies often causing adverse effects. Our research group identified αO-conotoxin GeXIVA[1,2] as a potent analgesic candidate derived from marine cone snails. However, its clinical application is limited by rapid clearance and complex administration. This study developed a sustained-release hydrogel microneedle patch encapsulating GeXIVA[1,2] to address these challenges. Optimized 4:3 (w/w) polyvinyl alcohol (PVA)–sucrose hydrogel formulation achieved 98.6% structural integrity and controlled swelling (ratio = 1.9 at 48 h). The microneedles demonstrated uniform conical morphology (height: 889 ± 49 µm, base: 381 ± 26 µm) enabling epidermal penetration. In spared nerve injury (SNI) models, a single microneedle patch application increased mechanical paw withdrawal thresholds from 0.056 g to 0.7269 g, maintaining efficacy for 3 days. Chronic constriction injury (CCI) models showed comparable pain relief. Notably, microneedle patch treatment improved locomotor function in SNI mice (total movement: 1518 cm vs. 1126 cm untreated). This hydrogel microneedle patch platform extends GeXIVA[1,2]’s analgesic duration from hours to days through sustained release, while resolving administration challenges through transdermal delivery, expanding the potential applications of GeXIVA[1,2], and demonstrating a promising strategy for the chronic neuropathic pain management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaConotoxinsAnalgesicsChronic PainAnimalsMiceDelayed-Action PreparationsHydrogelsNeedlesMaleDisease Models, AnimalPolyvinyl AlcoholTransdermal PatchDrug Delivery SystemsAdministration, Cutaneous

Stichwörter der Autor:innen

hydrogel encapsulationmicroneedle patchneuropathic painsustained releaseαO-conotoxin GeXIVA[1,2]

Substanzen

Delayed-Action PreparationsConotoxinsHydrogelsAnalgesicsPolyvinyl Alcohol

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning 530004, China.
  • Key Laboratory of Tropical Biological Resources of Ministry of Education, Hainan University, Haikou 570228, China.

ORCID-Profile: Sulan Luo

Förderung

  • Major Intergovernmental Joint Research Project of National Key R & D Program of China
  • Guangxi Natural Science Foundation
  • Major International Joint Research Project of National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • "Dai Tu Yi Zhi" Project of Key R & D Program of Guangxi
  • Key Project of Natural Science Foundation of Guangxi
  • Major Intergovernmental Joint Research Project of National Key R & D Program of China
  • “Dai Tu Yi Zhi” Project of Key R & D Program of Guangxi

Zitieren

APA

He, R., Li, M., Li, W., Li, W., Xiao, S., Cao, Q., Wang, H., Zhangsun, D., & Luo, S. (2025). Sustained Release of αO-Conotoxin GeXIVA[1,2] via Hydrogel Microneedle Patch for Chronic Neuropathic Pain Management. Marine Drugs. https://doi.org/10.3390/md23040161

Vancouver

He R, Li M, Li W, Li W, Xiao S, Cao Q, et al. Sustained Release of αO-Conotoxin GeXIVA[1,2] via Hydrogel Microneedle Patch for Chronic Neuropathic Pain Management. Marine Drugs. 2025. doi:10.3390/md23040161

BibTeX
@article{He2025,
  author = {He, Rongyan and Li, Mingjuan and Li, Weitao and Li, Wenqi and Xiao, Shuting and Cao, Qiuyu and Wang, Huanbai and Zhangsun, Dongting and Luo, Sulan},
  title = {Sustained Release of αO-Conotoxin GeXIVA[1,2] via Hydrogel Microneedle Patch for Chronic Neuropathic Pain Management},
  journal = {Marine Drugs},
  year = {2025},
  doi = {10.3390/md23040161}
}
Kostenlos starten →